REGENXBIO (RGNX) News Today $19.26 -0.32 (-1.63%) (As of 10:22 AM ET) Add Compare Share Share Today's Range$19.02▼$19.6750-Day Range$12.89▼$20.6052-Week Range$12.82▼$25.54Volume17,881 shsAverage Volume405,449 shsMarket Capitalization$847.25 millionP/E RatioN/ADividend YieldN/APrice Target$31.13 HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - December 3 at 1:40 AMREGENXBIO Announces Dose Escalation in AFFINITY DUCHENNE® Trialfinance.yahoo.com - November 29 at 9:35 AMWall Street Analysts Believe Regenxbio (RGNX) Could Rally 95.61%: Here's is How to Tradefinance.yahoo.com - November 16 at 2:48 PMREGENXBIO (NASDAQ:RGNX) adds US$111m to market cap in the past 7 days, though investors from five years ago are still down 72%finance.yahoo.com - November 12 at 9:51 AMREGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 9 at 5:30 PMRockville biotech RegenxBio to cut workforce by 15%, pursue strategic alternatives for several programsbizjournals.com - November 9 at 12:29 PMREGENXBIO Inc.: REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Resultsfinanznachrichten.de - November 9 at 7:29 AMRegenxbio Cutting 15% of Staff, Exploring Strategic Alternativesmarketwatch.com - November 8 at 9:29 PMREGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 8 at 4:28 PMEarnings Preview For Regenxbiobenzinga.com - November 7 at 12:48 PMREGENXBIO Presents Positive One Year Data from Phase II ALTITUDE® Trial of ABBV-RGX-314 for Treatment of Diabetic Retinopathy Using Suprachoroidal Deliveryfinance.yahoo.com - November 3 at 11:19 PMRegenxbio: Biotech To Watch With 2 Possible Accelerated Approval Pathwaysmsn.com - November 2 at 8:01 PMStifel Initiates Coverage of Regenxbio (RGNX) with Buy Recommendationmsn.com - November 2 at 10:00 AMStifel starts Regenxbio at buy; cites broad platform, deep portfoliomsn.com - November 1 at 6:36 PMREGENXBIO to Host Conference Call on November 8 to Discuss Third Quarter 2023 Financial Results and Recent Operational Highlightsfinance.yahoo.com - November 1 at 8:36 AMREGENXBIO Announces Presentations at the American Academy of Ophthalmology 2023 Annual Meetingfinance.yahoo.com - October 30 at 8:14 AMRegenxbio: Promising Yet Risky Therapeutic Horizonseekingalpha.com - October 25 at 6:05 AMWedbush Reiterates Regenxbio (RGNX) Neutral Recommendationmsn.com - October 6 at 11:32 PMPromising DMD Gene Therapy Results Bolster Buy Rating for RegenXBio: An Analysis of Brian Skorney’s Recommendationmarkets.businessinsider.com - October 5 at 9:52 AMREGENXBIO to Participate in the Jefferies CNS/Neuro Summitfinance.yahoo.com - October 5 at 9:52 AMHold Rating on REGENXBIO Amid Promising Yet Preliminary Duchenne Trial Resultsmarkets.businessinsider.com - October 4 at 11:43 PMRegenxbio up after hours on early-stage Duchenne candidateseekingalpha.com - October 4 at 12:24 AMOMEE, TNDM and RGNX are among after hour moversseekingalpha.com - October 3 at 7:23 PMREGENXBIO Presents Interim Clinical Data from Phase I/II AFFINITY DUCHENNE™ Trial of RGX-202 at 28th Annual International Congress of the World Muscle Societyfinance.yahoo.com - October 3 at 7:23 PMREGENXBIO Announces Presentations at the 28th Annual Congress of the World Muscle Societyfinance.yahoo.com - September 26 at 8:26 AMWe're Keeping An Eye On REGENXBIO's (NASDAQ:RGNX) Cash Burn Ratefinance.yahoo.com - September 22 at 1:31 PMREGENXBIO Inc. (NASDAQ:RGNX) Shares Purchased by Harbor Capital Advisors Inc.marketbeat.com - September 19 at 6:38 AMREGENXBIO Inc. (NASDAQ:RGNX) Given Average Recommendation of "Moderate Buy" by Analystsmarketbeat.com - September 19 at 2:41 AMCitigroup Inc. Purchases 34,856 Shares of REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - September 6 at 4:41 AMREGENXBIO Inc. (RGNX) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - September 5 at 4:10 AMRussell Investments Group Ltd. Acquires 51,116 Shares of REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - September 1 at 4:21 AMInitial Clinical Data of First Pediatric CLN2 Patient Dosed with RGX-181 Presented at SSIEM Annual Symposiumfinance.yahoo.com - August 30 at 4:56 PMREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by Analystsmarketbeat.com - August 25 at 2:36 AMREGENXBIO Announces Presentations at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2023finance.yahoo.com - August 23 at 4:51 PMBarclays PLC Sells 29,860 Shares of REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - August 21 at 4:34 AMJupiter Asset Management Ltd. Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - August 18 at 6:38 AMREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Victory Capital Management Inc.marketbeat.com - August 15 at 4:46 AMRegenxbio: RGX-314 Continues Advancing With Solid Financialsseekingalpha.com - August 10 at 1:23 AMLos Angeles Capital Management LLC Has $368,000 Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - August 9 at 6:12 AMREGENXBIO Inc. to Post Q3 2023 Earnings of ($1.26) Per Share, Leerink Partnrs Forecasts (NASDAQ:RGNX)marketbeat.com - August 7 at 2:25 AMRBC Capital Sticks to Its Hold Rating for RegenXBio (RGNX)markets.businessinsider.com - August 5 at 1:14 AMRoyce & Associates LP Has $3.45 Million Holdings in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - August 4 at 5:58 AMChardan Capital Reiterates Regenxbio (RGNX) Buy Recommendationmsn.com - August 4 at 3:35 AMRegenxbio Inc (RB0.MU)finance.yahoo.com - August 3 at 5:09 PMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: RegenXBio (RGNX) and Intercept Pharma (ICPT)markets.businessinsider.com - August 3 at 11:57 AMREGENXBIO Announces Participation at the 2023 Wedbush PacGrow Healthcare Conferencefinance.yahoo.com - August 1 at 9:11 PMREGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Rating of "Moderate Buy" by Brokeragesmarketbeat.com - July 31 at 1:48 AMREGENXBIO to Host Conference Call on August 2 to Discuss Second Quarter 2023 Financial Results and Recent Operational Highlightsfinance.yahoo.com - July 27 at 12:20 AMREGENXBIO Announces Upcoming Presentations at the American Society of Retina Specialists Annual Scientific Meetingfinance.yahoo.com - July 24 at 9:00 PMJennison Associates LLC Reduces Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)marketbeat.com - July 17 at 5:26 AM Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address RGNX Media Mentions By Week RGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼0.000.53▲Average Medical News Sentiment RGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼02▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADMA News SRRK News SANA News AUTL News TALS News APGE News EDIT News VALN News EXAI News INBX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:RGNX) was last updated on 12/11/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.